Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

Does Brazil Hold the Keys to Extreme Human Longevity?

Brazil’s genetically diverse population may offer a unique opportunity to advance research into the biological and environmental drivers of exceptional longevity.

Is ‘Brain Rot’ Real? What Short Videos May Do to Cognition

Emerging evidence suggests that while short-form videos may engage learners, they may also disrupt attention, memory, and brain networks essential for effective learning.

Going Dye-Free for IBD Surveillance: How Well Does It Work?

Virtual chromoendoscopy based on linked color imaging shows comparable performance to traditional dye-based chromoendoscopy for detecting neoplasia in patients with IBD.

Fecal Transplant Tied to Improved Sleep in Chronic Insomnia

A fecal microbiota transplantation protocol is linked to improved sleep efficiency and reduced wake after sleep onset in adults with chronic insomnia disorder, new research shows.

Antidepressants Tied to Altered Gut Microbiota in Depression

Treatment with widely used antidepressants is associated with a reduced abundance of a specific gut bacterium in patients with major depressive disorder.

Self-Management Toolkit Cuts Hospital Costs for Parkinson's

A facilitated self-management intervention for Parkinson's disease improves daily functioning and reduces healthcare costs over 12 months, driven primarily by fewer unplanned hospital admissions.

Todays Updates

Despite Medicare Coverage, Cancer Genomic Testing Still Low

Medicare coverage of next-generation sequencing may have spurred an increase in the number of patients receiving genomic tests. But uptake remains low.

Todays Updates

Despite Medicare Coverage, Cancer Genomic Testing Still Low

Medicare coverage of next-generation sequencing may have spurred an increase in the number of patients receiving genomic tests. But uptake remains low.

Latest News

Brazil’s genetically diverse population may offer a unique opportunity to advance research into the biological and environmental drivers of exceptional longevity.

Emerging evidence suggests that while short-form videos may engage learners, they may also disrupt attention, memory, and brain networks essential for effective learning.

Virtual chromoendoscopy based on linked color imaging shows comparable performance to traditional dye-based chromoendoscopy for detecting neoplasia in patients with IBD.

A fecal microbiota transplantation protocol is linked to improved sleep efficiency and reduced wake after sleep onset in adults with chronic insomnia disorder, new research shows.

Treatment with widely used antidepressants is associated with a reduced abundance of a specific gut bacterium in patients with major depressive disorder.

A facilitated self-management intervention for Parkinson's disease improves daily functioning and reduces healthcare costs over 12 months, driven primarily by fewer unplanned hospital admissions.

News All Time

Uterine-Preserving Surgery May Up Prolapse Retreatment Risk

Women who underwent uterine-preserving surgery for apical pelvic organ prolapse have a higher risk for retreatment than those who underwent hysterectomy with apical suspension.

Fingertip Sweat Patch Tracks Levodopa Levels in PD

A power-free fingertip patch continuously monitors levodopa in sweat, with readings that closely correlate with gold-standard blood testing in healthy participants and those with Parkinson’s disease.

Three Cancer Drugs Advance Toward Broader EU Use

Enhertu, Piqray, and Trodelvy moved closer to broader EU indications after CHMP backed new first-line combinations and expanded biomarker-based use in breast cancer.

Older Adults Advised to Limit Anticholinergic Medicines

The review examined 17 studies, all at serious or critical risk of bias, and could not confirm or exclude a causal link to dementia.

Overheard in Medicine: Betting on Clinical Trials?

Overhead in Medicine is a Medscape digest that surfaces a few of the week's top posts from major medical subreddits.

How Green Are Prescriptions? New Data Offer Clues

Researchers provide one of the first estimates of the carbon footprint of primary care prescribing, offering data to support more environmentally sustainable medication use.

EMA Clears One Rare Brain Disease Therapy, Rejects Another

European regulators recommended a treatment for childhood cerebral adrenoleukodystrophy but refused one for Niemann-Pick disease type C.

Oral Cancer Screening Identifies Lesions, Follow-Up Lags

Mobile screening units identify oral mucosal lesions in 1 in 20 individuals in Hungary.

GP Follow-Up Tied to Higher Cervical Surveillance Loss

Patients with cervical precancerous lesions followed by general practitioners showed higher rates of missed surveillance appointments than those monitored by gynecologists.

EU Panel Backs First Refillable Eye Implant for AMD

Susvimo, a refillable ranibizumab implant for neovascular age-related macular degeneration, could reduce treatment burden by replacing monthly injections with 24-week refills.

EMA Recommends New Hematology and Supportive Care Drugs

Ruxolitinib Viatris and Cavoley moved closer to EU approval, offering a bioequivalent option for hematologic disease and a biosimilar to help prevent chemotherapy-related febrile neutropenia.

Children Lose More Weight With Family-Based Treatment

A randomized trial found adding a family-based component to a weight management program for children in primary care resulted in greater reduction in body mass index.

FDA Approves First NDSRI for ADHD in Adults and Children

The FDA has approved Simtriyo (centanafadine) as the first norepinephrine, dopamine, serotonin reuptake inhibitor for adult and pediatric ADHD.

S4 Episode 6: Can Diet Improve Psoriasis Outcomes?

Many patients ask whether changing what they eat can help their psoriasis. Dr Joel Gelfand reviews the MEDIPSO trial and explains when a Mediterranean diet may meaningfully improve disease severity.

What Algorithms Cannot Heal: The Future of Rural Dermatology

Geographic barriers delay diagnoses, worsen outcomes, and increase morbidity from inflammatory skin disease and mortality from skin cancer, and patients often travel hours for specialty care.

Frailty Tied to Complications After Incontinence Surgery

Frailty is associated with complications and mortality within a year after stress urinary incontinence surgery in older men.

Recommended News For You

According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Can certain food cravings predict a cancer diagnosis up to three months before other symptoms appear?

A healthier lifestyle after bowel screening shown to prevent bowel cancer

Study sets benchmark for treatment of advanced cervical cancer

Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL

Study confirms link between breast density, higher breast cancer risk

Recommended Articles For You

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care 

Contemporary Trends in Oncology and Patient Outcomes 

Adaptive Rehabilitation Strategies for Advanced Cancer Survivorship 

Clinical Analysis of Prostate Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

2.

Radiation from CT scans could account for 5% of all cancer cases a year, study suggests

3.

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

4.

In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

5.

Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death

1.

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

2.

Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer

3.

Exploring the Use of Bevacizumab in Treating Different Types of Cancers 

4.

A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities

5.

Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

2.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

3.

A New Era in Managing Cancer-Associated Thrombosis

4.

Navigating the Complexities of Ph Negative ALL - Part IX

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot